
Sign up to save your podcasts
Or


In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors.
You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here.
By FEG Investment Advisors5
55 ratings
In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors.
You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here.

16,051 Listeners

3,075 Listeners

1,967 Listeners

87,529 Listeners

797 Listeners

357 Listeners

2,149 Listeners

10,182 Listeners

1,887 Listeners

187 Listeners